Texxon Holding Limited Announces Financial Results for Fiscal Year 2026
Texxon’s revenue plunged 39%, with losses deepening and liquidity now critically tight.
What the company is saying
Texxon frames its fiscal 2026 as a year of strategic transition, highlighting a proactive shift toward plastic particles and the completion of the Henan Polystyrene Factory. CEO Hui Xu emphasizes efforts to diversify revenue and build resilience, citing 14.2% growth in plastic particles revenue as partial offset to collapsing basic chemicals sales. The company attributes the 68.4% drop in basic chemicals revenue to resource reallocation and headcount cuts, prioritizing the factory’s construction and ramp-up. Management openly acknowledges near-term challenges, including soft demand and the time needed to scale new manufacturing, but maintains confidence in long-term growth from the new facility and business mix optimization. The tone is factual, with explanations for deteriorating margins and losses tied to deliberate pricing strategies and investment in future capacity, rather than short-term profitability.
What the data suggests
Fiscal 2026 revenue fell to $484.04 million from $797.15 million, a 39.3% decline, driven by a collapse in basic chemicals sales to $165.95 million from $524.64 million. Plastic particles revenue rose 14.2% to $310.98 million, but this growth was insufficient to offset the broader decline. Gross profit dropped 76.6% to $1.10 million, and gross margin compressed to 0.2%. Net loss widened to $8.99 million from $1.45 million, with net loss attributable to Texxon at $4.86 million versus $0.93 million prior. Operating expenses jumped 73.2% to $9.18 million, mainly due to higher salaries for senior hires and increased depreciation from the new factory. Cash and equivalents collapsed to $0.09 million at year-end, with net cash from operations at $1.76 million and heavy investment outflows of $15.03 million. The company’s narrative of strategic repositioning is supported by the numbers, but the financial trajectory is sharply negative, with liquidity now at minimal levels and profitability deteriorating.
Analysis
The announcement is factual and measured, providing detailed financial results and operational updates without exaggeration. All key claims are realised and supported by disclosed figures, including revenue, gross profit, net loss, and cash flow. The tone remains neutral, with no promotional or inflated language; forward-looking statements are present in the narrative but not in the headline or key claims. The financial direction is clearly negative, with revenue and profit declining and losses widening, and the company is transparent about these challenges. The only positive operational milestone is the completion and trial production start at the Henan Polystyrene Factory, but this is stated factually and does not overstate future benefits. There is a large capital outlay for the new factory, but the announcement does not claim immediate financial turnaround or outsized future returns.
Risk flags
- ●Liquidity risk is acute, with cash and cash equivalents at just $0.09 million as of June 30, 2026, raising the possibility of near-term funding needs or operational disruptions.
- ●Operational risk is elevated due to the transition from supply chain management to in-house manufacturing, with the Henan Polystyrene Factory not yet generating commercial revenue and requiring successful commissioning, customer qualification, and order ramp-up.
- ●Profitability risk is significant, as gross margin has compressed to 0.2% and net losses have widened, reflecting both competitive pricing strategies and increased fixed costs from new capacity.
- ●Execution risk around the new factory is high; delays or difficulties in scaling production or acquiring customers could further strain financials and delay any turnaround.
- ●Strategic risk exists from the sharp reduction in basic chemicals business and intentional headcount cuts, which may limit flexibility if market conditions do not improve or the new business lines underperform.
Bottom line
Texxon’s fiscal 2026 results show a company under severe financial pressure, with revenue down nearly 40%, gross profit and margin collapsing, and net losses surging. The shift toward plastic particles and the completion of the Henan Polystyrene Factory are positioned as long-term solutions, but the factory has yet to contribute commercial revenue and the company’s cash position is now critically low. Management’s strategy of sacrificing margin for customer base expansion and future manufacturing scale has not yet yielded financial improvement, and the risk of liquidity shortfall is immediate. Investors should focus on whether the new factory can ramp up quickly enough to stabilize cash flow and restore profitability, as any delay or execution misstep could force urgent capital raising or restructuring. The most important takeaway is that Texxon’s survival now hinges on rapid and successful commercialization of its new manufacturing capacity.
Track record
NewsStack has analysed 2 announcements from NPT since June 2026.
Previous NPT verdicts
- 30 Jun 2026Likely OverhypedTexxon Holding Limited Announces Unaudited Financial Results for the First Half of Fiscal Year 2026
Announcement summary
(NASDAQ:NPT) Texxon Holding Limited announced its financial results for the fiscal year ended June 30, 2026. Revenue for fiscal year 2026 was $484.04 million, compared to $797.15 million for fiscal year 2025. Revenue from sales of basic chemicals was $165.95 million for fiscal year 2026, down 68.4% from $524.64 million in fiscal year 2025. Revenue from sales of plastic particles was $310.98 million for fiscal year 2026, up 14.2% from $272.39 million in fiscal year 2025. Revenue from other products was $7.12 million for fiscal year 2026, compared to $0.12 million for fiscal year 2025, with the increase primarily attributable to black metal sales of approximately $7.0 million. Gross profit was $1.10 million for fiscal year 2026, compared to $4.70 million for fiscal year 2025. Gross profit margin was 0.2% for fiscal year 2026, compared to 0.6% for fiscal year 2025. Net loss was $8.99 million for fiscal year 2026, compared to $1.45 million for fiscal year 2025. Net loss attributable to Texxon was $4.86 million for fiscal year 2026, compared to $0.93 million for fiscal year 2025. Basic and diluted losses per share were $0.23 for fiscal year 2026, compared to $0.05 for fiscal year 2025. Cost of sales was $482.94 million for fiscal year 2026, a decrease of 39.1% from $792.45 million for fiscal year 2025. Operating expenses were $9.18 million for fiscal year 2026, up 73.2% from $5.30 million for fiscal year 2025. Selling expenses were $1.83 million for fiscal year 2026, down 24.3% from $2.41 million for fiscal year 2025. General and administrative expenses were $7.35 million for fiscal year 2026, up 154.6% from $2.89 million for fiscal year 2025. The increase in general and administrative expenses was primarily due to increases in salary and welfare benefits of approximately $1.9 million, depreciation and amortization of approximately $1.4 million, litigation settlements of approximately $0.4 million, expected credit loss provisions of approximately $0.3 million, office and utility expenses of approximately $0.3 million, and professional service fees of approximately $0.1 million. As of June 30, 2026, the company had cash and cash equivalents of $0.09 million, compared to $2.52 million as of June 30, 2025. Net cash provided by operating activities was $1.76 million for fiscal year 2026, compared to $2.32 million for fiscal year 2025. Net cash used in investing activities was $15.03 million for fiscal year 2026, compared to $42.25 million for fiscal year 2025. Net cash provided by financing activities was $10.39 million for fiscal year 2026, compared to $41.36 million for fiscal year 2025. The Henan Polystyrene Factory was substantially completed and available for use on May 6, 2026, with trial production commencing since June 2026. The company reallocated financial, personnel, and management resources from its supply chain management business to the factory and intentionally reduced headcount in the supply chain management business during fiscal year 2026. The company’s plastic particles business delivered 14.2% year-over-year revenue growth, supported by stronger market demand across sectors such as automotive, new energy, and chemicals. The company’s gross profit and margin decreased primarily due to a strategic shift toward serving major customers with more competitive pricing, prioritizing business scale and long-term customer relationships over short-term high-margin transactions. The increase in salary and welfare benefit expenses was primarily attributable to the addition of higher-compensated senior management and specialized personnel to support the construction, commissioning, and operational ramp-up of the Henan Polystyrene Factory, despite a net decrease in total headcount resulting from organizational streamlining during fiscal year 2026. The increase in depreciation and amortization was primarily due to the substantial completion of the Henan Polystyrene Factory and the commencement of depreciation.
Disagree with this article?
Ctrl + Enter to submit